Tablets
Tablets, Enteric-Coated
Chemistry, Pharmaceutical
Excipients
Drug Compounding
Delayed-Action Preparations
Technology, Pharmaceutical
Methylcellulose
Powders
Solubility
Hardness
Dosage Forms
Therapeutic Equivalency
Cellulose
Povidone
Biological Availability
Hardness Tests
Administration, Buccal
Compressive Strength
Carboxymethylcellulose Sodium
Suspensions
Polymethacrylic Acids
Pharmaceutic Aids
Cross-Over Studies
Drug Combinations
Acetaminophen
Porosity
Drug Packaging
Stearic Acids
Pharmaceutical Preparations
Tensile Strength
Multimedia
Television
Voice
Internet
Radio Waves
Voice Disorders
Pharmacokinetics of natural progesterone administered in the form of a vaginal tablet. (1/1213)
Our study was conducted to assess the pharmacokinetics of natural progesterone administered in the novel formula of an effervescent vaginal tablet. Fifty post-menopausal women, with a median age of 43.5 years (range 28-55), volunteered to participate in the research. All women discontinued their hormonal replacement therapy 1 month prior to the study. The pharmacokinetics of 50 and 100 mg of progesterone administered as a vaginal tablet were evaluated. After the initial administration of 50 mg or 100 mg, a mean serum Cmax of 20.43 +/- 8.01 nmol/l and 31.61 +/- 12.62 nmol/l (P < 0.0004) was reached at a Tmax of 6.1 +/- 2.63 and 6.4 +/- 3.35 h respectively. The terminal half-life was 13.18 +/- 1.3 and 13.7 +/- 1.05 h respectively. Continuous use of the 100-mg tablet resulted in a mean serum progesterone concentration of 26.08 +/- 13.96 nmol/l and 21.42 +/- 16.32 nmol/l after 14 and 30 days respectively. Women >40 years were found to have a significantly lower Tmax compared to younger women (P = 0.02). The continuous use of vaginal progesterone did not influence the hormonal, liver or lipid profiles evaluated. Only three (6%) women suffered from mild vaginal irritation. Natural progesterone given as a vaginal tablet is well tolerated, safe and an easily administered treatment. Even in a non-oestrogenized vagina the absorption was efficient and the 100 mg dosage resulted in adequate serum progesterone concentrations. (+info)Oral bioequivalence of three ciprofloxacin formulations following single-dose administration: 500 mg tablet compared with 500 mg/10 mL or 500 mg/5 mL suspension and the effect of food on the absorption of ciprofloxacin oral suspension. (2/1213)
The oral bioequivalence and tolerability of two ciprofloxacin formulations (tablet and suspension) and the effect of food on the absorption of ciprofloxacin oral suspension were investigated. Sixty-eight young, healthy male subjects participated in two separate, randomized, crossover studies. In study 1, ciprofloxacin as a single 500 mg tablet or as 500 mg/10 mL oral suspension was administered in a fasted state on day 1. In study 2, subjects participated in a three-way crossover study in which ciprofloxacin suspension was administered as 500 mg/10 mL in a fasted state, or 500 mg/10 mL with food, or 500 mg/5 mL in a fasted state. Plasma ciprofloxacin concentrations were measured by high-performance liquid chromatography. Standard pharmacokinetic parameters were estimated using non-compartmental methods. In study 1, geometric mean Cmax values of ciprofloxacin following the single 500 mg tablet and 500 mg/10 mL suspension doses were 2.36 and 2.18 mg/L, respectively; corresponding geometric mean t(max) values were 1.1 and 1.6 h, respectively. Geometric mean AUC(0-infinity) values were 12.0 and 11.8 mg x h/L, respectively. In study 2, geometric least squares mean Cmax values following ciprofloxacin 500 mg/10 mL and 500 mg/5 mL suspension during fasted conditions were 1.54 and 1.59 mg/L, respectively. Corresponding geometric least squares mean AUC(0-infinity) values were 7.3 and 8.0 mg x h/L. Administration of ciprofloxacin 500 mg/10 mL suspension, in either a fasted or fed state, was not associated with significant changes in Cmax (1.54 mg/L for fasted vs 1.37 mg/L for fed) or AUC(0-infinity) values (7.28 mg x h/L for fasted vs 8.19 mg x h/L for fed). Each ciprofloxacin formulation was well tolerated for the duration of each study. These studies demonstrated bioequivalence between ciprofloxacin 500 mg tablet and two strengths of ciprofloxacin suspension (500 mg/10 mL and 500 mg/5 mL). Bioavailability was unaltered by food. (+info)Comparison of phylloquinone bioavailability from food sources or a supplement in human subjects. (3/1213)
Phylloquinone (K) absorption was assessed in 22- to 30-y-old human subjects consuming a standard test meal [402 kcal (1682 kJ), 27% energy from fat]. The absorption of phylloquinone, measured over a 9-h period as the area under the curve (AUC), was higher (P < 0.01) after the consumption of a 500- microgram phylloquinone tablet [27.55 +/- 10.08 nmol/(L. h), n = 8] than after the ingestion of 495 microgram phylloquinone as 150 g of raw spinach [4.79 +/- 1.11 nmol/(L. h), n = 3]. Less phylloquinone (P < 0.05) was absorbed from 50 g of spinach (AUC = 2.49 +/- 1.11 nmol/(L. h) than from 150 g of spinach. Absorption of phylloquinone from fresh spinach (165 microgram K), fresh broccoli (184 microgram K) and fresh romaine lettuce (179 microgram K) did not differ. There was no difference in phylloquinone absorption from fresh or cooked broccoli or from fresh romaine lettuce consumed with a meal containing 30 or 45% energy as fat. (+info)Distribution of uranium in rats implanted with depleted uranium pellets. (4/1213)
During the Persian Gulf War, soldiers were injured with depleted uranium (DU) fragments. To assess the potential health risks associated with chronic exposure to DU, Sprague Dawley rats were surgically implanted with DU pellets at 3 dose levels (low, medium and high). Biologically inert tantalum (Ta) pellets were used as controls. At 1 day and 6, 12, and 18 months after implantation, the rats were euthanized and tissue samples collected. Using kinetic phosphorimetry, uranium levels were measured. As early as 1 day after pellet implantation and at all subsequent sample times, the greatest concentrations of uranium were in the kidney and tibia. At all time points, uranium concentrations in kidney and bone (tibia and skull) were significantly greater in the high-dose rats than in the Ta-control group. By 18 months post-implantation, the uranium concentration in kidney and bone of low-dose animals was significantly different from that in the Ta controls. Significant concentrations of uranium were excreted in the urine throughout the 18 months of the study (224 +/- 32 ng U/ml urine in low-dose rats and 1010 +/- 87 ng U/ml urine in high-dose rats at 12 months). Many other tissues (muscle, spleen, liver, heart, lung, brain, lymph nodes, and testicles) contained significant concentrations of uranium in the implanted animals. From these results, we conclude that kidney and bone are the primary reservoirs for uranium redistributed from intramuscularly embedded fragments. The accumulations in brain, lymph nodes, and testicles suggest the potential for unanticipated physiological consequences of exposure to uranium through this route. (+info)Effect of chronic magnesium supplementation on magnesium distribution in healthy volunteers evaluated by 31P-NMRS and ion selective electrodes. (5/1213)
AIMS: The role of magnesium (Mg) intake in the prevention and treatment of diseases is greatly debated. Mg biodistribution after chronic Mg supplementation was investigated, using state-of-the-art technology to detect changes in free ionized Mg, both at extra- and intracellular levels. METHODS: Thirty young healthy male volunteers participated in a randomised, placebo (P)-controlled, double-blind trial. The treated group (MgS) took 12 mmol magnesium lactate daily for 1 month. Subjects underwent in vivo 31P-NMR spectroscopy and complete clinical and biological examinations, on the first and last day of the trial. Total Mg was measured in plasma, red blood cells and 24 h urine ([Mg]U ). Plasma ionized Mg was measured by ion-selective electrodes. Intracellular free Mg concentrations of skeletal muscle and brain tissues were determined noninvasively by in vivo 31P-NMR at 3T. NMR data were automatically processed with the dedicated software MAGAN. RESULTS: Only [Mg]U changed significantly after treatment (in mmol/24 h, for P, from 4.2+/-1.4 before to 4.1+/-1.3 after and, for MgS, from 3.9+/-1.1 before to 5. 1+/-1.1 after, t=2.15, P=0.04). The two groups did not differ, either before or after the trial, in any other parameter, whether clinical, biological or in relation with the Mg status. CONCLUSIONS: Chronic oral administration of Mg tablets to young healthy male volunteers at usual pharmaceutical doses does not alter Mg biodistribution. This study shows that an adequate and very complete noninvasive methodology is now available and compatible with the organization of clinical protocols which aim at a thorough evaluation of Mg biodistribution. (+info)Gastrointestinal spread of oral prolonged-release mesalazine microgranules (Pentasa) dosed as either tablets or sachet. (6/1213)
BACKGROUND: There is increasing interest in using higher dosages of mesalazine for the treatment of inflammatory bowel disease; however, with current mesalazine products this involves the use of 8-16 tablets per day. AIM: To evaluate the disposition, dispersion and movements of Pentasa prolonged-release microgranules following single dosing of either tablets (2 x 500 mg) or a new 1 g sachet (unit dose, microgranules in a foil bag). METHODS: A randomized crossover study in eight healthy volunteers was undertaken. Both formulations were radiolabelled by neutron activation and dosed in the fasted state. Location of the preparations in the bowel was assessed over 24 h by scintigraphy. RESULTS: Dissolution testing at pH 7.5 showed comparable in vitro mesalazine release properties for the tablet and sachet preparations. In vivo disposition of the microgranules administered as either tablets or sachet was comparable in terms of gastric emptying, small intestinal transit and colon arrival. CONCLUSIONS: Pentasa sachets 1 g unit dose offers the same release of mesalazine as Pentasa 500 mg tablets. Drug release occurs throughout the gastrointestinal tract from stomach to colon, with the advantage of fewer oral doses and ease of swallowing. (+info)Huperzine-A in capsules and tablets for treating patients with Alzheimer disease. (7/1213)
AIM: To compare the efficacy and safety between huperzine-A (Hup) in capsules and tablets for treating patients with Alzheimer disease (AD). METHODS: Using multicenter, prospective, double-blind, double-mimic, parallel, positive controlled and randomized methods, 60 patients meeting with the NINCDS-ARDRA criteria of AD were divided into 2 equal groups. Patients in the capsule group received 4 capsules of Hup (each contains 50 micrograms) and 4 tablets of placebo (lactose and starch inside); while the tablet group received 4 tablets of Hup (each contains 50 micrograms) and 4 capsules of placebo, p.o., twice a day for 60 d. All the patients were evaluated with a lot of related ranting scales, and physiological and laboratory examination. RESULTS: There were significant differences (P < 0.01) on all the psychological evaluations between 'before' and 'after' the 60-d trial of 2 groups, but there was no significant difference between 2 groups by group t test (P > 0.05). The changes of oxygen free radicals in 2 groups showed marked improvement. No severe side effect besides moderate to mild nausea was found in both groups. CONCLUSION: There is equal efficacy and safety between Hup in capsule and tablet for treating patients with AD, and Hup can reduce the pathological changes of the oxygen free radicals in the plasma and erythrocytes of patients with AD. (+info)The application of VIS spectrophotometric determination of enalapril maleate in substance, in tablets and estimation of ester group stability. (8/1213)
A new spectrophotometric VIS method is proposed for the determination of enalapril maleate in pure substance and in tablets. Attempts have been made to estimate stability of the ester group in the molecule of enalapril maleate in the solid phase at 70 degrees C. (+info)In the context of medical terminology, tablets refer to pharmaceutical dosage forms that contain various active ingredients. They are often manufactured in a solid, compressed form and can be administered orally. Tablets may come in different shapes, sizes, colors, and flavors, depending on their intended use and the manufacturer's specifications.
Some tablets are designed to disintegrate or dissolve quickly in the mouth, making them easier to swallow, while others are formulated to release their active ingredients slowly over time, allowing for extended drug delivery. These types of tablets are known as sustained-release or controlled-release tablets.
Tablets may contain a single active ingredient or a combination of several ingredients, depending on the intended therapeutic effect. They are typically manufactured using a variety of excipients, such as binders, fillers, and disintegrants, which help to hold the tablet together and ensure that it breaks down properly when ingested.
Overall, tablets are a convenient and widely used dosage form for administering medications, offering patients an easy-to-use and often palatable option for receiving their prescribed treatments.
Enteric-coated tablets are a pharmaceutical formulation in which a tablet is coated with a polymeric material that is resistant to stomach acid. This coating allows the tablet to pass through the stomach intact and dissolve in the small intestine, where the pH is more neutral.
The enteric coating serves two main purposes:
1. It protects the active ingredient(s) from degradation by stomach acid, which can be particularly important for drugs that are unstable in acidic environments or that irritate the stomach lining.
2. It controls the release of the drug into the body, ensuring that it is absorbed in the small intestine rather than the stomach. This can help to improve the bioavailability of the drug and reduce side effects.
Enteric-coated tablets are commonly used for drugs that treat conditions affecting the gastrointestinal tract, such as ulcers or gastroesophageal reflux disease (GERD). They may also be used for drugs that have a narrow therapeutic index, meaning that the difference between an effective dose and a toxic dose is small. By controlling the release of these drugs into the body, enteric coating can help to ensure that they are absorbed at a consistent rate and reduce the risk of adverse effects.
Pharmaceutical chemistry is a branch of chemistry that deals with the design, synthesis, and development of chemical entities used as medications. It involves the study of drugs' physical, chemical, and biological properties, as well as their interactions with living organisms. This field also encompasses understanding the absorption, distribution, metabolism, and excretion (ADME) of drugs in the body, which are critical factors in drug design and development. Pharmaceutical chemists often work closely with biologists, medical professionals, and engineers to develop new medications and improve existing ones.
Excipients are inactive substances that serve as vehicles or mediums for the active ingredients in medications. They make up the bulk of a pharmaceutical formulation and help to stabilize, preserve, and enhance the delivery of the active drug compound. Common examples of excipients include binders, fillers, coatings, disintegrants, flavors, sweeteners, and colors. While excipients are generally considered safe and inert, they can sometimes cause allergic reactions or other adverse effects in certain individuals.
Drug compounding is the process of combining, mixing, or altering ingredients to create a customized medication to meet the specific needs of an individual patient. This can be done for a variety of reasons, such as when a patient has an allergy to a certain ingredient in a mass-produced medication, or when a patient requires a different dosage or formulation than what is available commercially.
Compounding requires specialized training and equipment, and compounding pharmacists must follow strict guidelines to ensure the safety and efficacy of the medications they produce. Compounded medications are not approved by the U.S. Food and Drug Administration (FDA), but the FDA does regulate the ingredients used in compounding and has oversight over the practices of compounding pharmacies.
It's important to note that while compounding can provide benefits for some patients, it also carries risks, such as the potential for contamination or incorrect dosing. Patients should only receive compounded medications from reputable pharmacies that follow proper compounding standards and procedures.
I couldn't find a medical definition specifically for "delayed-action preparations." However, in the context of pharmacology, it may refer to medications or treatments that have a delayed onset of action. These are designed to release the active drug slowly over an extended period, which can help to maintain a consistent level of the medication in the body and reduce the frequency of dosing.
Examples of delayed-action preparations include:
1. Extended-release (ER) or controlled-release (CR) formulations: These are designed to release the drug slowly over several hours, reducing the need for frequent dosing. Examples include extended-release tablets and capsules.
2. Transdermal patches: These deliver medication through the skin and can provide a steady rate of drug delivery over several days. Examples include nicotine patches for smoking cessation or fentanyl patches for pain management.
3. Injectable depots: These are long-acting injectable formulations that slowly release the drug into the body over weeks to months. An example is the use of long-acting antipsychotic injections for the treatment of schizophrenia.
4. Implantable devices: These are small, biocompatible devices placed under the skin or within a body cavity that release a steady dose of medication over an extended period. Examples include hormonal implants for birth control or drug-eluting stents used in cardiovascular procedures.
Delayed-action preparations can improve patient compliance and quality of life by reducing dosing frequency, minimizing side effects, and maintaining consistent therapeutic levels.
Medical technology, also known as health technology, refers to the use of medical devices, medicines, vaccines, procedures, and systems for the purpose of preventing, diagnosing, or treating disease and disability. This can include a wide range of products and services, from simple devices like tongue depressors and bandages, to complex technologies like MRI machines and artificial organs.
Pharmaceutical technology, on the other hand, specifically refers to the application of engineering and scientific principles to the development, production, and control of pharmaceutical drugs and medical devices. This can include the design and construction of manufacturing facilities, the development of new drug delivery systems, and the implementation of quality control measures to ensure the safety and efficacy of pharmaceutical products.
Both medical technology and pharmaceutical technology play crucial roles in modern healthcare, helping to improve patient outcomes, reduce healthcare costs, and enhance the overall quality of life for individuals around the world.
Methylcellulose is a semisynthetic, inert, viscous, and tasteless white powder that is soluble in cold water but not in hot water. It is derived from cellulose through the process of methylation. In medical contexts, it is commonly used as a bulk-forming laxative to treat constipation, as well as a lubricant in ophthalmic solutions and a suspending agent in pharmaceuticals.
When mixed with water, methylcellulose forms a gel-like substance that can increase stool volume and promote bowel movements. It is generally considered safe for most individuals, but like any medication or supplement, it should be used under the guidance of a healthcare provider.
In the context of medical terminology, "powders" do not have a specific technical definition. However, in a general sense, powders refer to dry, finely ground or pulverized solid substances that can be dispersed in air or liquid mediums. In medicine, powders may include various forms of medications, such as crushed tablets or capsules, which are intended to be taken orally, mixed with liquids, or applied topically. Additionally, certain medical treatments and therapies may involve the use of medicated powders for various purposes, such as drying agents, abrasives, or delivery systems for active ingredients.
Solubility is a fundamental concept in pharmaceutical sciences and medicine, which refers to the maximum amount of a substance (solute) that can be dissolved in a given quantity of solvent (usually water) at a specific temperature and pressure. Solubility is typically expressed as mass of solute per volume or mass of solvent (e.g., grams per liter, milligrams per milliliter). The process of dissolving a solute in a solvent results in a homogeneous solution where the solute particles are dispersed uniformly throughout the solvent.
Understanding the solubility of drugs is crucial for their formulation, administration, and therapeutic effectiveness. Drugs with low solubility may not dissolve sufficiently to produce the desired pharmacological effect, while those with high solubility might lead to rapid absorption and short duration of action. Therefore, optimizing drug solubility through various techniques like particle size reduction, salt formation, or solubilization is an essential aspect of drug development and delivery.
In the context of medical terminology, "hardness" is not a term that has a specific or standardized definition. It may be used in various ways to describe the firmness or consistency of a tissue, such as the hardness of an artery or tumor, but it does not have a single authoritative medical definition.
In some cases, healthcare professionals may use subjective terms like "hard," "firm," or "soft" to describe their tactile perception during a physical examination. For example, they might describe the hardness of an enlarged liver or spleen by comparing it to the feel of their knuckles when gently pressed against the abdomen.
However, in other contexts, healthcare professionals may use more objective measures of tissue stiffness or elasticity, such as palpation durometry or shear wave elastography, which provide quantitative assessments of tissue hardness. These techniques can be useful for diagnosing and monitoring conditions that affect the mechanical properties of tissues, such as liver fibrosis or cancer.
Therefore, while "hardness" may be a term used in medical contexts to describe certain physical characteristics of tissues, it does not have a single, universally accepted definition.
Oral administration is a route of giving medications or other substances by mouth. This can be in the form of tablets, capsules, liquids, pastes, or other forms that can be swallowed. Once ingested, the substance is absorbed through the gastrointestinal tract and enters the bloodstream to reach its intended target site in the body. Oral administration is a common and convenient route of medication delivery, but it may not be appropriate for all substances or in certain situations, such as when rapid onset of action is required or when the patient has difficulty swallowing.
Medical definitions of "lubricants" refer to substances that are used to reduce friction between two surfaces in medical procedures or devices. They can be used during various medical examinations, surgeries, or when inserting medical equipment, such as catheters, to make the process smoother and more comfortable for the patient.
Lubricants used in medical settings may include water-based gels, oil-based jellies, or silicone-based lubricants. It's important to choose a lubricant that is safe and suitable for the specific medical procedure or device being used. For example, some lubricants may not be compatible with certain medical materials or may need to be sterile.
It's worth noting that while lubricants are commonly used in medical settings, they should not be used as a substitute for proper medical care or treatment. If you have any concerns about your health or medical condition, it's important to consult with a qualified healthcare professional.
A dosage form refers to the physical or pharmaceutical preparation of a drug that determines how it is administered and taken by the patient. The dosage form influences the rate and extent of drug absorption, distribution, metabolism, and excretion in the body, which ultimately affects the drug's therapeutic effectiveness and safety profile.
There are various types of dosage forms available, including:
1. Solid dosage forms: These include tablets, capsules, caplets, and powders that are intended to be swallowed or chewed. They may contain a single active ingredient or multiple ingredients in a fixed-dose combination.
2. Liquid dosage forms: These include solutions, suspensions, emulsions, and syrups that are intended to be taken orally or administered parenterally (e.g., intravenously, intramuscularly, subcutaneously).
3. Semi-solid dosage forms: These include creams, ointments, gels, pastes, and suppositories that are intended to be applied topically or administered rectally.
4. Inhalation dosage forms: These include metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers that are used to deliver drugs directly to the lungs.
5. Transdermal dosage forms: These include patches, films, and sprays that are applied to the skin to deliver drugs through the skin into the systemic circulation.
6. Implantable dosage forms: These include surgically implanted devices or pellets that release drugs slowly over an extended period.
The choice of dosage form depends on various factors, such as the drug's physicochemical properties, pharmacokinetics, therapeutic indication, patient population, and route of administration. The goal is to optimize the drug's efficacy and safety while ensuring patient compliance and convenience.
Therapeutic equivalence refers to the concept in pharmaceutical medicine where two or more medications are considered to be equivalent in clinical efficacy and safety profiles. This means that they can be used interchangeably to produce the same therapeutic effect.
Two products are deemed therapeutically equivalent if they contain the same active ingredient(s), are available in the same dosage form and strength, and have been shown to have comparable bioavailability, which is a measure of how much and how quickly a drug becomes available for use in the body.
It's important to note that therapeutic equivalence does not necessarily mean that the medications are identical or have identical excipients (inactive ingredients). Therefore, patients who may have sensitivities or allergies to certain excipients should still consult their healthcare provider before switching between therapeutically equivalent medications.
In many countries, including the United States, the Food and Drug Administration (FDA) maintains a list of therapeutic equivalence evaluations for generic drugs, known as the "Orange Book." This resource helps healthcare providers and patients make informed decisions about using different versions of the same medication.
A capsule is a type of solid pharmaceutical dosage form in which the drug is enclosed in a small shell or container, usually composed of gelatin or other suitable material. The shell serves to protect the drug from degradation, improve its stability and shelf life, and facilitate swallowing by making it easier to consume. Capsules come in various sizes and colors and can contain one or more drugs in powder, liquid, or solid form. They are typically administered orally but can also be used for other routes of administration, such as rectal or vaginal.
Cellulose is a complex carbohydrate that is the main structural component of the cell walls of green plants, many algae, and some fungi. It is a polysaccharide consisting of long chains of beta-glucose molecules linked together by beta-1,4 glycosidic bonds. Cellulose is insoluble in water and most organic solvents, and it is resistant to digestion by humans and non-ruminant animals due to the lack of cellulase enzymes in their digestive systems. However, ruminants such as cows and sheep can digest cellulose with the help of microbes in their rumen that produce cellulase.
Cellulose has many industrial applications, including the production of paper, textiles, and building materials. It is also used as a source of dietary fiber in human food and animal feed. Cellulose-based materials are being explored for use in biomedical applications such as tissue engineering and drug delivery due to their biocompatibility and mechanical properties.
Povidone, also known as PVP or polyvinylpyrrolidone, is not a medication itself but rather a pharmaceutical ingredient used in various medical and healthcare products. It is a water-soluble synthetic polymer that has the ability to bind to and carry other substances, such as drugs or iodine.
In medical applications, povidone is often used as a binder or coating agent in pharmaceutical tablets and capsules. It can also be found in some topical antiseptic solutions, such as those containing iodine, where it helps to stabilize and control the release of the active ingredient.
It's important to note that while povidone is a widely used pharmaceutical ingredient, it is not typically considered a medication on its own.
Drug stability refers to the ability of a pharmaceutical drug product to maintain its physical, chemical, and biological properties during storage and use, under specified conditions. A stable drug product retains its desired quality, purity, strength, and performance throughout its shelf life. Factors that can affect drug stability include temperature, humidity, light exposure, and container compatibility. Maintaining drug stability is crucial to ensure the safety and efficacy of medications for patients.
Biological availability is a term used in pharmacology and toxicology that refers to the degree and rate at which a drug or other substance is absorbed into the bloodstream and becomes available at the site of action in the body. It is a measure of the amount of the substance that reaches the systemic circulation unchanged, after administration by any route (such as oral, intravenous, etc.).
The biological availability (F) of a drug can be calculated using the area under the curve (AUC) of the plasma concentration-time profile after extravascular and intravenous dosing, according to the following formula:
F = (AUCex/AUCiv) x (Doseiv/Doseex)
where AUCex is the AUC after extravascular dosing, AUCiv is the AUC after intravenous dosing, Doseiv is the intravenous dose, and Doseex is the extravascular dose.
Biological availability is an important consideration in drug development and therapy, as it can affect the drug's efficacy, safety, and dosage regimen. Drugs with low biological availability may require higher doses to achieve the desired therapeutic effect, while drugs with high biological availability may have a more rapid onset of action and require lower doses to avoid toxicity.
A hardness test is a quantitative measure of a material's resistance to deformation, typically defined as the penetration of an indenter with a specific shape and load into the surface of the material being tested. There are several types of hardness tests, including Rockwell, Vickers, Brinell, and Knoop, each with their own specific methods and applications. The resulting hardness value is used to evaluate the material's properties, such as wear resistance, durability, and suitability for various industrial or manufacturing processes. Hardness tests are widely used in materials science, engineering, and quality control to ensure the consistency and reliability of materials and components.
Buccal administration refers to the route of delivering a medication or drug through the buccal mucosa, which is the lining of the inner cheek in the mouth. This route allows for the medication to be absorbed directly into the bloodstream, bypassing the gastrointestinal tract and liver metabolism, which can result in faster onset of action and potentially higher bioavailability.
Buccal administration can be achieved through various forms of dosage forms such as lozenges, tablets, films, or sprays that are placed in contact with the buccal mucosa for a certain period of time until they dissolve or disintegrate and release the active ingredient. This route is commonly used for medications that require a rapid onset of action, have poor oral bioavailability, or are irritating to the gastrointestinal tract.
It's important to note that buccal administration may not be appropriate for all medications, as some drugs may be inactivated by saliva or may cause local irritation or discomfort. Therefore, it's essential to consult with a healthcare professional before using any medication through this route.
Compressive strength is a measure of the maximum compressive load that a material or structure can withstand before failure or deformation. It is typically expressed in units of pressure, such as pounds per square inch (psi) or megapascals (MPa). Compressive strength is an important property in the design and analysis of structures and materials, as it helps to ensure their safety and durability under compressive loads.
In medical terminology, compressive strength may refer to the ability of biological tissues, such as bone or cartilage, to withstand compressive forces without deforming or failing. For example, osteoporosis is a condition characterized by reduced bone density and compressive strength, which can increase the risk of fractures in affected individuals. Similarly, degenerative changes in articular cartilage can lead to decreased compressive strength and joint pain or stiffness.
Carboxymethylcellulose sodium is a type of cellulose derivative that is widely used in the medical and pharmaceutical fields as an excipient or a drug delivery agent. It is a white, odorless powder with good water solubility and forms a clear, viscous solution.
Chemically, carboxymethylcellulose sodium is produced by reacting cellulose, which is derived from plant sources such as wood or cotton, with sodium hydroxide and chloroacetic acid. This reaction introduces carboxymethyl groups (-CH2COO-) to the cellulose molecule, making it more soluble in water and providing negative charges that can interact with positively charged ions or drugs.
In medical applications, carboxymethylcellulose sodium is used as a thickening agent, binder, disintegrant, and suspending agent in various pharmaceutical formulations such as tablets, capsules, liquids, and semisolids. It can also be used as a lubricant in the manufacture of tablets and capsules to facilitate their ejection from molds or dies.
Carboxymethylcellulose sodium has been shown to have good biocompatibility and low toxicity, making it a safe and effective excipient for use in medical and pharmaceutical applications. However, like any other excipient, it should be used with caution and in appropriate amounts to avoid any adverse effects or interactions with the active ingredients of the drug product.
In the context of medical definitions, "suspensions" typically refers to a preparation in which solid particles are suspended in a liquid medium. This is commonly used for medications that are administered orally, where the solid particles disperse upon shaking and settle back down when left undisturbed. The solid particles can be made up of various substances such as drugs, nutrients, or other active ingredients, while the liquid medium is often water, oil, or alcohol-based.
It's important to note that "suspensions" in a medical context should not be confused with the term as it relates to pharmacology or physiology, where it may refer to the temporary stopping of a bodily function or the removal of something from a solution through settling or filtration.
Polymethacrylic acids are not typically referred to as a medical term, but rather as a chemical one. They are a type of synthetic polymer made up of repeating units of methacrylic acid (MAA). These polymers have various applications in different industries, including the medical field.
In medicine, polymethacrylates are often used in the formulation of controlled-release drug delivery systems, such as beads or microspheres, due to their ability to swell and shrink in response to changes in pH or temperature. This property allows for the gradual release of drugs encapsulated within these polymers over an extended period.
Polymethacrylates are also used in dental applications, such as in the production of artificial teeth and dentures, due to their durability and resistance to wear. Additionally, they can be found in some surgical sealants and adhesives.
While polymethacrylic acids themselves may not have a specific medical definition, their various forms and applications in medical devices and drug delivery systems contribute significantly to the field of medicine.
Pharmaceutic aids, also known as pharmaceutical excipients or additives, are substances that are added to pharmaceutical formulations during the manufacturing process. They are not intended to have any therapeutic effect, but rather to improve the drug's stability, bioavailability, palatability, or patient compliance.
Examples of pharmaceutic aids include binders, fillers, coatings, disintegrants, preservatives, coloring agents, and flavoring agents. Binders help hold the active ingredients together in a solid form, while fillers are used to add bulk to the formulation. Coatings can be used to protect the drug from degradation or to make it easier to swallow. Disintegrants help the tablet or capsule break down quickly in the digestive tract so that the active ingredient can be absorbed more efficiently. Preservatives are added to prevent microbial growth, while coloring and flavoring agents improve the appearance and taste of the medication.
It is important to note that pharmaceutic aids must undergo rigorous testing to ensure their safety and compatibility with the active ingredients in the drug formulation. Some people may have allergies or sensitivities to certain excipients, so it is essential to consider these factors when developing and prescribing medications.
A cross-over study is a type of experimental design in which participants receive two or more interventions in a specific order. After a washout period, each participant receives the opposite intervention(s). The primary advantage of this design is that it controls for individual variability by allowing each participant to act as their own control.
In medical research, cross-over studies are often used to compare the efficacy or safety of two treatments. For example, a researcher might conduct a cross-over study to compare the effectiveness of two different medications for treating high blood pressure. Half of the participants would be randomly assigned to receive one medication first and then switch to the other medication after a washout period. The other half of the participants would receive the opposite order of treatments.
Cross-over studies can provide valuable insights into the relative merits of different interventions, but they also have some limitations. For example, they may not be suitable for studying conditions that are chronic or irreversible, as it may not be possible to completely reverse the effects of the first intervention before administering the second one. Additionally, carryover effects from the first intervention can confound the results if they persist into the second treatment period.
Overall, cross-over studies are a useful tool in medical research when used appropriately and with careful consideration of their limitations.
Sublingual administration refers to a route of delivering medication or other substances through placement under the tongue, allowing for rapid absorption into the bloodstream through the mucous membranes located there. This method can allow for quick onset of action and avoids first-pass metabolism in the liver that may occur with oral administration. Common examples of sublingual medications include nitroglycerin for angina pectoris and certain forms of hormone replacement therapy.
A drug combination refers to the use of two or more drugs in combination for the treatment of a single medical condition or disease. The rationale behind using drug combinations is to achieve a therapeutic effect that is superior to that obtained with any single agent alone, through various mechanisms such as:
* Complementary modes of action: When different drugs target different aspects of the disease process, their combined effects may be greater than either drug used alone.
* Synergistic interactions: In some cases, the combination of two or more drugs can result in a greater-than-additive effect, where the total response is greater than the sum of the individual responses to each drug.
* Antagonism of adverse effects: Sometimes, the use of one drug can mitigate the side effects of another, allowing for higher doses or longer durations of therapy.
Examples of drug combinations include:
* Highly active antiretroviral therapy (HAART) for HIV infection, which typically involves a combination of three or more antiretroviral drugs to suppress viral replication and prevent the development of drug resistance.
* Chemotherapy regimens for cancer treatment, where combinations of cytotoxic agents are used to target different stages of the cell cycle and increase the likelihood of tumor cell death.
* Fixed-dose combination products, such as those used in the treatment of hypertension or type 2 diabetes, which combine two or more active ingredients into a single formulation for ease of administration and improved adherence to therapy.
However, it's important to note that drug combinations can also increase the risk of adverse effects, drug-drug interactions, and medication errors. Therefore, careful consideration should be given to the selection of appropriate drugs, dosing regimens, and monitoring parameters when using drug combinations in clinical practice.
Acetaminophen is a medication used to relieve pain and reduce fever. It is a commonly used over-the-counter drug and is also available in prescription-strength formulations. Acetaminophen works by inhibiting the production of prostaglandins, chemicals in the body that cause inflammation and trigger pain signals.
Acetaminophen is available in many different forms, including tablets, capsules, liquids, and suppositories. It is often found in combination with other medications, such as cough and cold products, sleep aids, and opioid pain relievers.
While acetaminophen is generally considered safe when used as directed, it can cause serious liver damage or even death if taken in excessive amounts. It is important to follow the dosing instructions carefully and avoid taking more than the recommended dose, especially if you are also taking other medications that contain acetaminophen.
If you have any questions about using acetaminophen or are concerned about potential side effects, it is always best to consult with a healthcare professional.
In the context of medical terminology, "porosity" is not a term that is frequently used to describe human tissues or organs. However, in dermatology and cosmetics, porosity refers to the ability of the skin to absorb and retain moisture or topical treatments.
A skin with high porosity has larger pores and can absorb more products, while a skin with low porosity has smaller pores and may have difficulty absorbing products. It is important to note that this definition of porosity is not a medical one but is instead used in the beauty industry.
"Drug storage" refers to the proper handling, maintenance, and preservation of medications in a safe and suitable environment to ensure their effectiveness and safety until they are used. Proper drug storage includes:
1. Protecting drugs from light, heat, and moisture: Exposure to these elements can degrade the quality and potency of medications. Therefore, it is recommended to store most drugs in a cool, dry place, away from direct sunlight.
2. Keeping drugs out of reach of children and pets: Medications should be stored in a secure location, such as a locked cabinet or medicine chest, to prevent accidental ingestion or harm to young children and animals.
3. Following storage instructions on drug labels and packaging: Some medications require specific storage conditions, such as refrigeration or protection from freezing. Always follow the storage instructions provided by the manufacturer or pharmacist.
4. Regularly inspecting drugs for signs of degradation or expiration: Check medications for changes in color, consistency, or odor, and discard any that have expired or show signs of spoilage.
5. Storing drugs separately from one another: Keep different medications separate to prevent cross-contamination, incorrect dosing, or accidental mixing of incompatible substances.
6. Avoiding storage in areas with high humidity or temperature fluctuations: Bathrooms, kitchens, and garages are generally not ideal for storing medications due to their exposure to moisture, heat, and temperature changes.
Proper drug storage is crucial for maintaining the safety, efficacy, and stability of medications. Improper storage can lead to reduced potency, increased risk of adverse effects, or even life-threatening situations. Always consult a healthcare professional or pharmacist for specific storage instructions and recommendations.
Drug packaging refers to the process and materials used to enclose, protect, and provide information about a pharmaceutical product. The package may include the container for the medication, such as a bottle or blister pack, as well as any accompanying leaflets or inserts that contain details about the drug's dosage, side effects, and proper use.
The packaging of drugs serves several important functions:
1. Protection: Proper packaging helps to protect the medication from physical damage, contamination, and degradation due to exposure to light, moisture, or air.
2. Child-resistance: Many drug packages are designed to be child-resistant, meaning they are difficult for young children to open but can still be easily accessed by adults.
3. Tamper-evidence: Packaging may also include features that make it easy to detect if the package has been tampered with or opened without authorization.
4. Labeling: Drug packaging must comply with regulatory requirements for labeling, including providing clear and accurate information about the drug's ingredients, dosage, warnings, and precautions.
5. Unit-dose packaging: Some drugs are packaged in unit-dose form, which means that each dose is individually wrapped or sealed in a separate package. This can help to reduce medication errors and ensure that patients receive the correct dosage.
6. Branding and marketing: Drug packaging may also serve as a tool for branding and marketing the product, with distinctive colors, shapes, and graphics that help to differentiate it from similar products.
Stearic acid is not typically considered a medical term, but rather a chemical compound. It is a saturated fatty acid with the chemical formula C18H36O2. Stearic acid is commonly found in various foods such as animal fats and vegetable oils, including cocoa butter and palm oil.
In a medical context, stearic acid might be mentioned in relation to nutrition or cosmetics. For example, it may be listed as an ingredient in some skincare products or medications where it is used as an emollient or thickening agent. It's also worth noting that while stearic acid is a saturated fat, some studies suggest that it may have a more neutral effect on blood cholesterol levels compared to other saturated fats. However, this is still a topic of ongoing research and debate in the medical community.
Pharmaceutical preparations refer to the various forms of medicines that are produced by pharmaceutical companies, which are intended for therapeutic or prophylactic use. These preparations consist of an active ingredient (the drug) combined with excipients (inactive ingredients) in a specific formulation and dosage form.
The active ingredient is the substance that has a therapeutic effect on the body, while the excipients are added to improve the stability, palatability, bioavailability, or administration of the drug. Examples of pharmaceutical preparations include tablets, capsules, solutions, suspensions, emulsions, ointments, creams, and injections.
The production of pharmaceutical preparations involves a series of steps that ensure the quality, safety, and efficacy of the final product. These steps include the selection and testing of raw materials, formulation development, manufacturing, packaging, labeling, and storage. Each step is governed by strict regulations and guidelines to ensure that the final product meets the required standards for use in medical practice.
Tensile strength is a material property that measures the maximum amount of tensile (pulling) stress that a material can withstand before failure, such as breaking or fracturing. It is usually measured in units of force per unit area, such as pounds per square inch (psi) or pascals (Pa). In the context of medical devices or biomaterials, tensile strength may be used to describe the mechanical properties of materials used in implants, surgical tools, or other medical equipment. High tensile strength is often desirable in these applications to ensure that the material can withstand the stresses and forces it will encounter during use.
I'm sorry for any confusion, but "multimedia" is not a term that has a specific medical definition. Multimedia generally refers to the use of multiple forms of media, such as text, audio, video, graphics, and animation, in a single interactive presentation or platform. It is often used in various fields including education, entertainment, marketing, and some areas of healthcare for purposes like training, patient education, and therapy. However, it does not have a specific medical meaning itself.
I'm sorry for any confusion, but "Television" is a consumer electronic device and does not have a medical definition. It is used for receiving and displaying broadcast television programs through an antenna, satellite dish, or cable provider. If you have any medical questions or terms you would like defined, I'd be happy to help!
In medical terms, the term "voice" refers to the sound produced by vibration of the vocal cords caused by air passing out from the lungs during speech, singing, or breathing. It is a complex process that involves coordination between respiratory, phonatory, and articulatory systems. Any damage or disorder in these systems can affect the quality, pitch, loudness, and flexibility of the voice.
The medical field dealing with voice disorders is called Phoniatrics or Voice Medicine. Voice disorders can present as hoarseness, breathiness, roughness, strain, weakness, or a complete loss of voice, which can significantly impact communication, social interaction, and quality of life.
I'm sorry for any confusion, but "Internet" is a term that pertains to the global network of interconnected computers and servers that enable the transmission and reception of data via the internet protocol (IP). It is not a medical term and does not have a specific medical definition. If you have any questions related to medicine or health, I'd be happy to try to help answer them for you!
Radio waves are not a medical term, but rather a type of electromagnetic radiation with frequencies ranging from about 30 kilohertz (kHz) to 300 gigahertz (GHz). They have longer wavelengths and lower frequencies than other types of electromagnetic radiation such as microwaves, infrared light, visible light, ultraviolet light, X-rays, and gamma rays.
In the medical field, radio waves are used in various diagnostic and therapeutic applications, including:
* Diagnostic imaging: Magnetic resonance imaging (MRI) uses radio waves in combination with a strong magnetic field to generate detailed images of internal organs and tissues.
* Radiation therapy: High-energy radio waves are used to destroy cancer cells or shrink tumors in radiation therapy.
* Cardiac ablation: Radiofrequency ablation is a medical procedure that uses radio waves to destroy small areas of heart tissue that cause abnormal heart rhythms.
It's important to note that while radio waves have many medical applications, they are not themselves a medical term or condition.
Voice disorders are conditions that affect the quality, pitch, or volume of a person's voice. These disorders can result from damage to or abnormalities in the vocal cords, which are the small bands of muscle located in the larynx (voice box) that vibrate to produce sound.
There are several types of voice disorders, including:
1. Vocal cord dysfunction: This occurs when the vocal cords do not open and close properly, resulting in a weak or breathy voice.
2. Vocal cord nodules: These are small growths that form on the vocal cords as a result of excessive use or misuse of the voice, such as from shouting or singing too loudly.
3. Vocal cord polyps: These are similar to nodules but are usually larger and can cause more significant changes in the voice.
4. Laryngitis: This is an inflammation of the vocal cords that can result from a viral infection, overuse, or exposure to irritants such as smoke.
5. Muscle tension dysphonia: This occurs when the muscles around the larynx become tense and constricted, leading to voice changes.
6. Paradoxical vocal fold movement: This is a condition in which the vocal cords close when they should be open, causing breathing difficulties and a weak or breathy voice.
7. Spasmodic dysphonia: This is a neurological disorder that causes involuntary spasms of the vocal cords, resulting in voice breaks and difficulty speaking.
Voice disorders can cause significant impairment in communication, social interactions, and quality of life. Treatment may include voice therapy, medication, or surgery, depending on the underlying cause of the disorder.